Yes, there are genetic variations in the DHFR gene that can affect the enzyme's activity and the individual's response to drugs. Polymorphisms in the DHFR gene can influence the effectiveness of antifolate drugs and are a subject of pharmacogenetic studies. Identifying these variations can help tailor personalized treatment plans for patients.